Exelixis EXEL Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's total cost of revenue?
- Exelixis (EXEL) reported total cost of revenue of $19.95M in Q1 2026.
- How has Exelixis's total cost of revenue changed year-over-year?
- Exelixis's total cost of revenue increased by 4.1% year-over-year, from $19.17M to $19.95M.
- What is the long-term trend for Exelixis's total cost of revenue?
- Over 4 years (2021 to 2025), Exelixis's total cost of revenue has grown at a 12.2% compound annual growth rate (CAGR), from $52.87M to $83.7M.
- What does total cost of revenue mean?
- The direct costs associated with producing and delivering the goods sold to customers.
- How do you interpret total cost of revenue?
- An increase relative to revenue may signal rising manufacturing costs or unfavorable changes in product mix, while a decrease suggests improved operational efficiency.
- How does total cost of revenue compare across companies?
- Commonly referred to as Cost of Goods Sold (COGS) in the biopharmaceutical industry.